Revalor-XR 200 mg Implant is a Health Canada–registered veterinary drug (DIN 02469316) held by Intervet Canada Corp, containing Trenbolone Acetate. Health Canada lists its status as Marketed (status date 09 May 2018). Nexara Health has matched 3 registrations of Trenbolone Acetate across 1 other regulated market.
Health Canada registration
| DIN | 02469316 |
|---|---|
| Brand name | Revalor-XR |
| Active ingredient | Trenbolone Acetate |
| Strength | 200 mg |
| Dosage form | Implant |
| Route | Subcutaneous |
| Company | Intervet Canada Corp |
| Status | Marketed — 09 May 2018 |
| Class | Veterinary |
| ATC | |
| AHFS | |
| Regulator record | Health Canada DPD entry · Product monograph |
Trenbolone Acetate registered in other markets
3 registrations of the same molecule in 1 national registry outside Canada. Each row is taken from the regulator's own published list; status is shown as the registry reports it.
| Country | Product | Marketing authorisation holder | Strength | Form | Status | Registry |
|---|---|---|---|---|---|---|
| United States | Trenbolone acetate | Valdepharm | Powder | FDA NDC | ||
| United States | Trenbolone Acetate | Pharmacia and Upjohn Company LLC | Powder | FDA NDC | ||
| United States | Trenbolone Acetate | Laurus Synthesis Pvt Ltd | Powder | FDA NDC |
See every manufacturer of Trenbolone Acetate worldwide →
Marketed Canadian products with the same active ingredient
| DIN | Product | Company | Strength | Form |
|---|---|---|---|---|
| 02429136 | Revalor-100 | Intervet Canada Corp | 10 mg | Implant |
| 02254026 | Revalor-200 | Intervet Canada Corp | 200 mg | Implant |
Sourcing through Nexara Health
Nexara Health is a Health Canada–licensed wholesaler (DEL #3-002896) in Winnipeg. Because this DIN is marketed in Canada, supply normally comes through the Canadian channel; where the Canadian presentation is short or discontinued, the registrations above show which regulated markets hold an equivalent that can be imported under the Special Access Programme or for clinical comparator use. Request a quote or read how named-patient and foreign-pack supply works in Canada.
Frequently asked questions
Is Revalor-XR (DIN 02469316) marketed in Canada?
Yes. Health Canada lists DIN 02469316 as Marketed as of 09 May 2018.
Who holds the Canadian licence for this product?
Intervet Canada Corp is the company of record in the Health Canada Drug Product Database.
Is Trenbolone Acetate registered outside Canada?
Yes — Nexara Health has matched 3 registrations in 1 other market (see the table above).
Where does this data come from?
Health Canada Drug Product Database (DPD), DIN 02469316, status date 2018-05-09; national medicine registries: FDA NDC. Nexara Health re-checks these sources weekly and shows the last verification date at the top of the page.
Source: Health Canada Drug Product Database (DPD), DIN 02469316, status date 2018-05-09; national medicine registries: FDA NDC.
Health Canada Drug Product Database (DPD), DIN 02469316, status date 2018-05-09; national medicine registries: FDA NDC. Last reviewed 2026-09-16. Nexara Health is a licensed wholesaler and supplies licensed entities only; consumer orders are routed to a partner pharmacy.